Home › NDC Lookup › Labelers › Ipsen Biopharmaceuticals, Inc.

Ipsen Biopharmaceuticals, Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 15054 (Ipsen Biopharmaceuticals, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

19
Package NDCs
23
Products
23
Active listings
0
Discontinued
7
Ingredients
1
Therapeutic classes
7
Dosage forms
0
With NADAC pricing

Portfolio

By therapeutic class
NEUROMUSCULAR BLOCKING AGENTS 2
Top ingredients
palovarotene 10
odevixibat 4
lanreotide acetate 3
elafibranor 2
Botulinum Toxin Type A 2
IRINOTECAN HYDROCHLORIDE 1
mecasermin 1
By dosage form
CAPSULE 12
INJECTION 3
TABLET, FILM COATED 2
INJECTION, POWDER, LYOPHILIZED, FO... 2
CAPSULE, COATED PELLETS 2
INJECTION, POWDER, FOR SOLUTION 1
INJECTION, SOLUTION 1

Browse records — 23 products

Drug / product Billing NDC NADAC / unit Status
Bylvay odevixibat 400 ug/1 CAPSULE Ipsen · NDC 15054-3302-01 · 1 BOTTLE in 1 CARTON (15054-3302-1) / 30 CAPSULE in 1 BOTTLE 15054-3302-01 — On market View →
Bylvay odevixibat 200 ug/1 CAPSULE, COATED PELLETS Ipsen · NDC 15054-3301-01 · 1 BOTTLE in 1 CARTON (15054-3301-1) / 30 CAPSULE, COATED PELLETS in 1 BOTTLE 15054-3301-01 — On market View →
Bylvay odevixibat 1200 ug/1 CAPSULE Ipsen · NDC 15054-3304-01 · 1 BOTTLE in 1 CARTON (15054-3304-1) / 30 CAPSULE in 1 BOTTLE 15054-3304-01 — On market View →
Bylvay odevixibat 600 ug/1 CAPSULE, COATED PELLETS Ipsen · NDC 15054-3303-01 · 1 BOTTLE in 1 CARTON (15054-3303-1) / 30 CAPSULE, COATED PELLETS in 1 BOTTLE 15054-3303-01 — On market View →
Dysport Botulinum Toxin Type A 500 U/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Ipsen · NDC 15054-0500-01 · J0586 · 1 VIAL in 1 CARTON (15054-0500-1) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL 15054-0500-01 — On market View →
Dysport Botulinum Toxin Type A 300 U/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Ipsen · NDC 15054-0530-06 · J0586 · 1 VIAL in 1 CARTON (15054-0530-6) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL 15054-0530-06 — On market View →
Increlex mecasermin 40 mg/4mL INJECTION, SOLUTION Ipsen · NDC 15054-1040-05 · 1 VIAL, MULTI-DOSE in 1 CARTON (15054-1040-5) / 4 mL in 1 VIAL, MULTI-DOSE 15054-1040-05 — On market View →
IQIRVO elafibranor 80 mg/1 TABLET, FILM COATED Ipsen · NDC 15054-0080-01 · 1 BOTTLE in 1 CARTON (15054-0080-1) / 30 TABLET, FILM COATED in 1 BOTTLE 15054-0080-01 — On market View →
IQIRVO elafibranor 80 mg/1 TABLET, FILM COATED Ipsen · NDC 15054-0080-01 · 1 BOTTLE in 1 CARTON (15054-0080-1) / 30 TABLET, FILM COATED in 1 BOTTLE 15054-0080-01 — On market View →
Onivyde IRINOTECAN HYDROCHLORIDE 4.3 mg/mL INJECTION, POWDER, FOR SOLUTION Ipsen · NDC 15054-0043-01 · J9205 · 1 VIAL, SINGLE-DOSE in 1 CARTON (15054-0043-1) / 10 mL in 1 VIAL, SINGLE-DOSE 15054-0043-01 — On market View →
SOHONOS palovarotene 5 mg/1 CAPSULE Ipsen · NDC 15054-0050-01 · 1 BLISTER PACK in 1 CARTON (15054-0050-1) / 14 CAPSULE in 1 BLISTER PACK 15054-0050-01 — On market View →
SOHONOS palovarotene 1.5 mg/1 CAPSULE Ipsen · NDC 15054-0015-01 · 1 BLISTER PACK in 1 CARTON (15054-0015-1) / 14 CAPSULE in 1 BLISTER PACK 15054-0015-01 — On market View →
SOHONOS palovarotene 2.5 mg/1 CAPSULE Ipsen · NDC 15054-0025-01 · 1 BLISTER PACK in 1 CARTON (15054-0025-1) / 14 CAPSULE in 1 BLISTER PACK 15054-0025-01 — On market View →
SOHONOS palovarotene 1 mg/1 CAPSULE Ipsen · NDC 15054-0010-01 · 1 BLISTER PACK in 1 CARTON (15054-0010-1) / 14 CAPSULE in 1 BLISTER PACK 15054-0010-01 — On market View →
SOHONOS palovarotene 10 mg/1 CAPSULE Ipsen · NDC 15054-0100-01 · 1 BLISTER PACK in 1 CARTON (15054-0100-1) / 14 CAPSULE in 1 BLISTER PACK 15054-0100-01 — On market View →
SOHONOS palovarotene 5 mg/1 CAPSULE Ipsen · NDC 15054-0050-01 · 1 BLISTER PACK in 1 CARTON (15054-0050-1) / 14 CAPSULE in 1 BLISTER PACK 15054-0050-01 — On market View →
SOHONOS palovarotene 10 mg/1 CAPSULE Ipsen · NDC 15054-0100-01 · 1 BLISTER PACK in 1 CARTON (15054-0100-1) / 14 CAPSULE in 1 BLISTER PACK 15054-0100-01 — On market View →
SOHONOS palovarotene 2.5 mg/1 CAPSULE Ipsen · NDC 15054-0025-01 · 1 BLISTER PACK in 1 CARTON (15054-0025-1) / 14 CAPSULE in 1 BLISTER PACK 15054-0025-01 — On market View →
SOHONOS palovarotene 1.5 mg/1 CAPSULE Ipsen · NDC 15054-0015-01 · 1 BLISTER PACK in 1 CARTON (15054-0015-1) / 14 CAPSULE in 1 BLISTER PACK 15054-0015-01 — On market View →
SOHONOS palovarotene 1 mg/1 CAPSULE Ipsen · NDC 15054-0010-01 · 1 BLISTER PACK in 1 CARTON (15054-0010-1) / 14 CAPSULE in 1 BLISTER PACK 15054-0010-01 — On market View →
SOMATULINE DEPOT lanreotide acetate 60 mg/.2mL INJECTION Ipsen · NDC 15054-1060-04 · J1930 · 1 POUCH in 1 CARTON (15054-1060-4) / 1 SYRINGE in 1 POUCH / .2 mL in 1 SYRINGE 15054-1060-04 — On market View →
SOMATULINE DEPOT lanreotide acetate 90 mg/.3mL INJECTION Ipsen · NDC 15054-1090-04 · J1930 · 1 POUCH in 1 CARTON (15054-1090-4) / 1 SYRINGE in 1 POUCH / .3 mL in 1 SYRINGE 15054-1090-04 — On market View →
SOMATULINE DEPOT lanreotide acetate 120 mg/.5mL INJECTION Ipsen · NDC 15054-1120-04 · J1930 · 1 POUCH in 1 CARTON (15054-1120-4) / 1 SYRINGE in 1 POUCH / .5 mL in 1 SYRINGE 15054-1120-04 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.